Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2010
09/16/2010CA2754604A1 Compositions and methods for elimination of gram-negative bacteria
09/16/2010CA2754601A1 Sphingosine kinase inhibitor prodrugs
09/16/2010CA2754592A1 Hapten-carrier conjugates with bacterial toxins having a signal peptide as carrier and their use in immunogenic compositions
09/16/2010CA2754589A1 Steroid compound
09/16/2010CA2754562A1 Rosuvastatin and atorvastatin derivatives
09/16/2010CA2754542A1 Oxo-heterocyclically substituted alkyl carboxylic acids and use thereof
09/16/2010CA2754276A1 New crystalline form vi of agomelatine, preparation method and application thereof
09/16/2010CA2753685A1 Highly compactable and durable direct compression excipients and excipient systems
09/16/2010CA2753285A1 Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents for the treatment of hematopoietic malignancies
09/16/2010CA2753135A1 Pyrazolo[1,5-.alpha.]-1,3,5-triazine derivatives, preparation thereof, and therapeutic use thereof
09/16/2010CA2753061A1 Novel hetero pyrrole analogs acting on cannabinoid receptors
09/16/2010CA2752713A1 Pharmaceutical formulation comprising ketoprofen and a polyoxyalkylene ester of a hydroxy fatty acid
09/16/2010CA2752246A1 Process for manufacturing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1- hydroxyethyl)-8-hydroxyquinolin-2(1h)-one
09/16/2010CA2752045A1 Process for the preparation of bosentan
09/16/2010CA2751901A1 Mineralocorticoid receptor antagonist and methods of use
09/16/2010CA2749819A1 Tricyclic heterocyclic derivatives
09/16/2010CA2748963A1 Tetrahydronaphthalen-2-ol derivatives
09/16/2010CA2748856A1 Riluzole aqueous suspensions
09/15/2010EP2228654A2 Diagnosis and prevention of cancer cell invasion
09/15/2010EP2228385A1 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
09/15/2010EP2228384A1 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
09/15/2010EP2228380A1 Novel triterpene derivatives
09/15/2010EP2228378A1 Monosebacate of pyrazole derivative
09/15/2010EP2228376A1 Pyripyropene derivative having acat2-inhibiting activity
09/15/2010EP2228375A1 New xanthin derivatives, their production and utilisation as medicine
09/15/2010EP2228369A1 Pyrazole derivatives as protein kinase modulators
09/15/2010EP2228368A1 Process for manufacturing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one
09/15/2010EP2228367A1 Addition salts of amines containing hydroxyl and/or carboxylic groups with amino nicotinic acid derivatives as DHODH inhibitors
09/15/2010EP2228365A1 Pharmaceutical combination of 5-fluorouracil and derivative of 1,4-dihydropyridine and its use in the treatment of cancer
09/15/2010EP2228364A1 Acylsulfonamides as inhibitors of steroid sulfatase
09/15/2010EP2228066A1 Pharmaceutical compositions of sulphonylurea-based active pharmaceutical ingredient with excellent dissolution properties
09/15/2010EP2228065A2 Heterocyclo inhibitors of potassium channel function
09/15/2010EP2228064A2 Pharmaceutical composition containing glycopyrrolate and a beta2 adrenoceptor agonist
09/15/2010EP2228063A1 Loxoprofen-containing aqueous plaster
09/15/2010EP2228062A1 Compositions containing a phospholipid-curcumin complex and piperine as chemosensitizing agent
09/15/2010EP2228060A1 Oral dosage forms comprising fenofibrate
09/15/2010EP2228058A1 Anionic oil-in-water emulsion containing prostaglandins and uses thereof
09/15/2010EP2228057A1 Cationic oil-in-water emulsions containing prostaglandins and uses thereof
09/15/2010EP2228056A2 Tolperisone controlled release tablet
09/15/2010EP2228055A1 Riluzole liquid emulsions
09/15/2010EP2228054A1 Riluzole aqueous suspensions
09/15/2010EP2228035A1 Use of alginate matrices to control cell growth
09/15/2010EP2227770A2 Prolyl hydroxylase inhibitors
09/15/2010EP2227496A1 Cationic beataine precursors to zwitterionic betaines having controlled biological properties
09/15/2010EP2227482A1 2',4'-substituted nucleosides as antiviral agents
09/15/2010EP2227478A1 Process and intermediates for the preparation of substituted 1, 3-oxathiolanes, especially lamivudine
09/15/2010EP2227476A1 Tricyclic triazolic compounds
09/15/2010EP2227475A1 Isoxazolopyridine derivatives for use in the treatment of hif-mediated conditions
09/15/2010EP2227474A1 Azo and diaza derivatives and uses thereof in phototherapy
09/15/2010EP2227473A2 Polymorphs of a c-met/hgfr inhibitor
09/15/2010EP2227472A1 Aryl and heteroaryl fused imidazo (1,5-a) pyrazines as inhibitors of phosphodiesterase 10
09/15/2010EP2227471A1 Gamma secretase modulators
09/15/2010EP2227470A1 Naphthalene diimide compounds interacting with g-quadruplex regions in dna
09/15/2010EP2227469A1 Mapk/erk kinase inhibitors
09/15/2010EP2227467A1 Isoxazolo-pyridine derivatives
09/15/2010EP2227466A2 Heteroaryl-substituted piperidines
09/15/2010EP2227464A1 Derivatives of 1-[(imidazolidin-2-yl)imino)]indazole
09/15/2010EP2227463A1 Substituted oxindole-derivatives and the use thereof for the treatment of vasopressin-dependent illnesses
09/15/2010EP2227461A1 New compounds iii
09/15/2010EP2227460A1 Therapeutic oxy-phenyl-aryl compounds and their use
09/15/2010EP2227459A2 Phenyl-oxetanyl-derivatives
09/15/2010EP2227456A2 Hedgehog pathway antagonists and therapeutic applications thereof
09/15/2010EP2227455A1 Trisubstituted 3,4-dihydro-1h-isoquinolin compound, process for its preparation, and its use
09/15/2010EP2227453A2 Heteroaryl amides useful as inhibitors of voltage-gated sodium channels
09/15/2010EP2227452A2 Pyridine compounds
09/15/2010EP2227450A2 Selective estrogen receptor modulator compositions and methods for treatment of disease
09/15/2010EP2227245A2 Combination of protein tyrosine phosphatase inhibitors and human growth hormone for the treatment of muscle atrophy and related disorders
09/15/2010EP2227243A2 A pharmaceutical composition for treating obesity-related disease comprising insulinotropic peptide conjugate
09/15/2010EP2227236A2 Methods and compositions for reducing activity of the atrial natriuretic peptide receptor and for treatment of diseases
09/15/2010EP2227234A1 Method for inducing hepatocyte proliferation and uses thereof
09/15/2010EP2227233A2 Ido inhibitors
09/15/2010EP2227232A1 Methods for inhibiting t helper cell differentiation
09/15/2010EP2227230A1 Method for applying a polymer coating to an internal surface of a container
09/15/2010EP2227229A2 Compositions comprising coenzyme q-10 and garlic oil for an increased coenzyme q-10 bioavailability
09/15/2010EP2227226A2 Manufacture of tablet
09/15/2010EP2227224A2 Improved pharmaceutical composition containing non-ergoline dopamine agonist and method for the preparation thereof
09/15/2010EP2227221A1 Effervescent tablets and effervescent granules containing carnitine tartrate
09/15/2010EP2227213A1 Compositions and methods for treating vaginal infections and pathogenic vaginal biofilms
09/15/2010EP2227087A1 Cbi derivatives subject to reductive activation
09/15/2010EP2227085A1 Inhalable compositions having enhanced bioavailability
09/15/2010EP2094709B1 Thiazole pyrazolopyrimidines as crf1 receptor antagonists
09/15/2010EP2079690B1 3-aza-bicyclo[3.1.0]hexane derivatives
09/15/2010EP2066669B1 Adenosine derivatives as a2a receptor agonists
09/15/2010EP2027132B1 Thiazolo-pyramidine / pyridine urea derivatives as adenosine a2b receptor antagonists
09/15/2010EP2001887B1 Pyrrolo-quinoxalinone derivatives as antibacterials
09/15/2010EP1968561B1 Treatment of diabetic nephropathy
09/15/2010EP1926705B3 Process for preparing valsartan
09/15/2010EP1910314B1 Benzimidazole derivatives for treatment of inflammatory diseases
09/15/2010EP1909816B1 Cnf1 bacterial toxin protein from e. coli as analgesic
09/15/2010EP1899303B1 Novel 3-aza-spiro[5.5]undecane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
09/15/2010EP1899301B1 Novel 3-aza-spiro[5.5]undec-8-ene derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
09/15/2010EP1874282B1 Methods and compositions for treatment of cns disorders
09/15/2010EP1866314B1 Novel diazabicyclic aryl derivatives and their medical use
09/15/2010EP1861092B1 Potassium channel opener having benzofuroindole skeleton
09/15/2010EP1830857B1 Beclomethasone dipropionate and prednisone for reducing mortality associated with graft-versus-host disease
09/15/2010EP1811999B1 Quinuclidine derivatives and their use as muscarinic m3 receptor antagonists
09/15/2010EP1805177B9 Pyrrolo[3,2-c]pyridine derivatives and process for the preparation thereof
09/15/2010EP1758596B9 Purine derivatives as adenosine a1 receptor agonists and methods of use thereof
09/15/2010EP1751156B1 6,7,8,9-substituted 1-phenyl-1,5-dihydro-pyrido(3,2-b)indol-2-ones useful as anti-infective pharmaceutical agents
09/15/2010EP1725295B1 Compositions and use of tyrosine kinase inhibitors to treat pathogenic infection
1 ... 2091 2092 2093 2094 2095 2096 2097 2098 2099 2100 2101 2102 2103 2104 2105 2106 2107 2108 2109 2110 2111 ... 7860